Proceedings of the National Academy of Sciences · 2007 · 147 citations · 14 references
Life SciencesGeneticsNeuroscienceMolecular NeurobiologyMolecular NeuroscienceNeurogeneticsCharcot-marie-tooth DiseaseGenetic DisordersHereditary NeuropathiesMolecular NeurogeneticsNeurodegenerative DiseasesNeurogenetic DisordersAminoacyl-transfer Ribonucleic Acid Synthetase Disease MutationsDimer Interface
Charcot-Marie-Tooth (CMT) diseases are the most common heritable peripheral neuropathy. At least 10 different mutant alleles of GARS (the gene for glycyl-tRNA synthetase) have been reported to cause a dominant axonal form of CMT (type 2D). A unifying connection between these mutations and CMT has been unclear. Here, mapping mutations onto the recently determined crystal structure of human GlyRS showed them within a band encompassing both sides of the dimer interface, with two CMT-causing mutations being at sites that are complementary partners of a "kissing" contact across the dimer interface. The CMT phenotype is shown here to not correlate with aminoacylation activity. However, most mutations affect dimer formation (to enhance or weaken). Seven CMT-causing variants and the wild-type protein were expressed in transfected neuroblastoma cells that sprout primitive neurites. Wild-type GlyRS distributed into the nascent neurites and was associated with normal neurite sprouting. In contrast, all mutant proteins were distribution-defective. Thus, CMT-causing mutations of GlyRS share a common defect in localization. This defect may be connected in some way to a change in the surfaces at the dimer interface.
14
Genetic and clinical aspects of Charcot‐Marie‐Tooth's disease
H. Skre · Clinical Genetics · 1974 · 903 citations
Anthony Antonellis, Rachel E. Ellsworth, Nyamkhishig Sambuughin et al. · The American Journal of Human Genetics · 2003 · 566 citations · Full text
Rajan Sankaranarayanan, Anne‐Catherine Dock‐Brégeon, Pascale Romby et al. · Cell · 1999 · 311 citations · Full text